Literature DB >> 15485754

Correlates of hypertension control in a primary care setting.

Thomas G Majernick1, Christopher Zacker, Nancy A Madden, Daniel A Belletti, Stephen Arcona.   

Abstract

BACKGROUND: Numerous clinical trials have demonstrated reduction in cardiovascular events as a result of lowering blood pressure (BP). Despite these findings, BP control rates, especially in primary care settings, remain suboptimal. This study describes hypertension control and its predictors, using data from a sample of 631 adult patients drawn from an established primary care practice.
METHODS: Data were obtained through chart review and patient survey during a 3-month period. The BP control was the outcome in a logistic regression model identifying demographic and clinical predictors of control.
RESULTS: Compared to patients with low Framingham Risk Scores (FRS), individuals with moderate and high scores had reduced odds of achieving control (69% reduction, 95% confidence interval [CI] 0.19-0.65; 82% reduction, 95% CI 0.10-0.36, respectively). Being female reduced the odds of control by 61% (95% CI 0.26-0.66). Having diabetes mellitus (DM) (95% CI 0.21-0.79) or impaired fasting glucose (IFG; fasting glucose >109 but <126 mg/dL) (95% CI 0.10-0.40) reduced the odds of control by 64% and 82%, respectively. For each additional point on a physician-rated patient knowledge scale, the odds of having controlled BP increased 78% (95% CI 1.44-2.56). Each additional co-morbid condition positively associated with control (34% increase in odds, 95% CI 1.15-1.86). Age (95% CI 0.98-1.02) and body mass index (BMI) (95% CI 0.97-1.04) had no effect.
CONCLUSIONS: Higher FRS, female sex, DM, and IFG negatively correlated with control. Patient knowledge and number of co-morbid conditions correlated positively. Age and BMI did not correlate with control. The most disturbing finding in our study was that higher risk patients who stand to benefit most from BP control were least likely to be controlled, despite being on more antihypertensive medications. These findings may be helpful to primary care providers in reaching patient hypertension control goals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485754     DOI: 10.1016/j.amjhyper.2004.05.016

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

1.  Sociodemographics and hypertension control among young adults with incident hypertension: a multidisciplinary group practice observational study.

Authors:  Ryan C Haggart; Christie M Bartels; Maureen A Smith; Heather M Johnson
Journal:  J Hypertens       Date:  2018-12       Impact factor: 4.844

2.  Racial/Ethnic Differences in Knowledge of Personal and Target Levels of Cardiovascular Health Indicators.

Authors:  Mindy Ma; Alyson Ma
Journal:  J Community Health       Date:  2015-10

3.  Medication non-adherence and blood pressure control among hypertensive migrant and non-migrant populations of sub-Saharan African origin: the RODAM study.

Authors:  Erik Beune; Pythia Nieuwkerk; Karien Stronks; Karlijn Meeks; Matthias B Schulze; Frank P Mockenhaupt; Ina Danquah; Kerstin Klipstein-Grobusch; Peter Agyei-Baffour; Joachim Spranger; Juliet Addo; Liam Smeeth; Charles Agyemang
Journal:  J Hum Hypertens       Date:  2018-10-15       Impact factor: 3.012

4.  Age-dependent gender differences in hypertension management.

Authors:  Stacie L Daugherty; Frederick A Masoudi; Jennifer L Ellis; P Michael Ho; Julie A Schmittdiel; Heather M Tavel; Joe V Selby; Patrick J O'Connor; Karen L Margolis; David J Magid
Journal:  J Hypertens       Date:  2011-05       Impact factor: 4.844

5.  Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States.

Authors:  Daniel A Belletti; Christopher Zacker; Jenifer Wogen
Journal:  Cardiovasc Diabetol       Date:  2010-02-01       Impact factor: 9.951

6.  Adherence to antihypertensive medications and associations with blood pressure among African Americans with hypertension in the Jackson Heart Study.

Authors:  Mark J Butler; Rikki M Tanner; Paul Muntner; Daichi Shimbo; Adam P Bress; Amanda J Shallcross; Mario Sims; Gbenga Ogedegbe; Tanya M Spruill
Journal:  J Am Soc Hypertens       Date:  2017-07-06

7.  The Efficacy of Perindopril/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL Study.

Authors:  Ayman Abdelhady; Said Khader; Samy Sinnuqrut; Abdullah Albow
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859

8.  Sex Disparity in Blood Pressure Levels Among Nigerian Health Workers.

Authors:  Abiodun M Adeoye; Adewole Adebiyi; Mayowa O Owolabi; Daniel T Lackland; Gbenga Ogedegbe; Bamidele O Tayo
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-19       Impact factor: 3.738

9.  Obesity & hypertension are determinants of poor hemodynamic control during total joint arthroplasty: a retrospective review.

Authors:  Benedict U Nwachukwu; Jamie E Collins; Emily P Nelson; Mercedes Concepcion; Thomas S Thornhill; Jeffrey N Katz
Journal:  BMC Musculoskelet Disord       Date:  2013-01-14       Impact factor: 2.362

10.  Rate and predictors of blood pressure control in a federal qualified health center in Michigan: a huge concern?

Authors:  Adesuwa B Olomu; Venu Gourineni; Jason L Huang; Nirzari Pandya; Nephertiti Efeovbokhan; Janaki Samaraweera; Kamesh Parashar; Margaret Holmes-Rovner
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.